Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110277 · ClinicalTrials.gov registry record · NA
Photoacoustic Imaging of the Ovary
A NA study, sponsored by UConn Health.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02110277 is a NA study that was terminated before completion, run by UConn Health. The registered enrollment target is 2 participants.
The verdict
NCT02110277, a NA study, was terminated before completion, sponsored by UConn Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to develop technology to image the ovaries in order to better evaluate ovarian disease and to study how these experimental imaging techniques might work together or separately to improve our ability to detect ovarian cancer.
Interventions
- DEVICE PAI/ultrasound Diagnostic Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02110277
The ClinicalTrials.gov registry entry for NCT02110277 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PAI/ultrasound Diagnostic Group is the first listed.
NCT02110277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02110277 about?
NCT02110277 is a clinical study titled "Photoacoustic Imaging of the Ovary". The purpose of this study is to develop technology to image the ovaries in order to better evaluate ovarian disease and to study how these experimental imaging techniques might work together or separately to improve our ability to detect ovarian cancer.
What is the current status of trial NCT02110277?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2014-03. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02110277?
The interventions under investigation include: PAI/ultrasound Diagnostic Group (DEVICE).
Who is sponsoring clinical trial NCT02110277?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.